Is Treace Medical Concepts (NASDAQ:TMCI) Weighed On By Its Debt Load?
Truist Financial Maintains Treace Medical Concepts(TMCI.US) With Hold Rating, Raises Target Price to $8.4
Express News | Treace Medical Concepts Inc : Truist Securities Raises Target Price to $8.4 From $7
Express News | JP Morgan Assumes Treace Medical Concepts at Neutral, Announces Price Target of $8
Treace Announces First Surgical Cases Utilizing the SpeedPlate MicroQuad Implant
Treace Announces First Cases Utilizing RedPoint Intelliguide Patient Specific Instrumentation With the Adductoplasty System for Correction of Midfoot Deformities
(SHORT) then when you FEEL it's a spike back up for a BULL 
Cover (Sell) your SHORT then renter for a BULL 
and SEEING EVERYTHING not one way.
